Targeted Inhibition of Pancreatic Acinar Cell Calcineurin Is a Novel Strategy to Prevent Post-ERCP Pancreatitis  by Orabi, Abrahim I. et al.
ORIGINAL RESEARCHTargeted Inhibition of Pancreatic Acinar Cell Calcineurin Is a
Novel Strategy to Prevent Post-ERCP Pancreatitis
Abrahim I. Orabi,1,* Li Wen,1,* Tanveer A. Javed,1 Tianming Le,1 Ping Guo,2
Subramaniam Sanker,1 David Ricks,2 Kristy Boggs,1 John F. Eisses,1 Carlos Castro,3
Xiangwei Xiao,2 Krishna Prasadan,2 Farzad Esni,2 George K. Gittes,2 and Sohail Z. Husain1
1Department of Pediatric GI, 2Department of Pediatric Surgery, University of Pittsburgh School of Medicine, Pittsburgh,
Pennsylvania; 3Magee-Womens Research Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania*Authors share co-ﬁrst authorship.
Abbreviations used in this paper: AAV, adeno-associated virus; Cn,
calcineurin; CreERT2, Cre recombinase estrogen receptor T2; CsA,
cyclosporine A; Ela, pancreatic elastase I; ERCP, endoscopic
retrograde cholangiopancreatography; IL, interleukin; LSL, Lox-Stop-
Lox; LVNS, low volume normal saline; MPO, myeloperoxidase; PEG,SUMMARY
This work establishes that pancreatic acinar cell calcineurin
is a critical mediator of post–endoscopic retrograde
cholangiopancreatography pancreatitis, using a mouse
model. Importantly, the work led us to discover that
calcineurin inhibitors, infused along with the radiocontrast,
largely can prevent the procedural complication.
BACKGROUND & AIMS: There is a pressing need to develop
effective preventative therapies for post–endoscopic retro-
grade cholangiopancreatography pancreatitis (PEP). We
showed that early PEP events are induced through the
calcium-activated phosphatase calcineurin and that global
calcineurin deletion abolishes PEP in mice. A crucial question
is whether acinar cell calcineurin controls the initiation of PEP
in vivo.
METHODS: We used a mouse model of PEP and examined the
effects of in vivo acinar cell-speciﬁc calcineurin deletion by
either generating a conditional knockout line or infusing a
novel adeno-associated virus–pancreatic elastase improved Cre
(I–iCre) into the pancreatic duct of a calcineurin ﬂoxed line.
RESULTS: We found that PEP is dependent on acinar cell
calcineurin in vivo, and this led us to determine that calcineurin
inhibitors, infused within the radiocontrast, largely can prevent
PEP.
CONCLUSIONS: These results provide the impetus for launch-
ing clinical trials to test the efﬁcacy of intraductal calcineurin
inhibitors to prevent PEP. (Cell Mol Gastroenterol Hepatol
2016;-:-–-; http://dx.doi.org/10.1016/j.jcmgh.2016.08.006)
Keywords: Adeno-Associated Virus; Calcineurin B1; FK506;
Cyclosporine A; Intraductal Delivery.
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http://dx.doi.org/10.1016/j.jcmgh.2016.08.006E(ERCP) is a common gastrointestinal procedure that
confers a risk of acute pancreatitis ranging between 1% and
15%.1 The efﬁcacy of widely accepted strategies to prevent
post-ERCP pancreatitis (PEP) such as pretreatment with
rectal indomethacin2 recently have been challenged.3,4 The
search for PEP prevention requires uncovering centralmechanisms that initiate PEP. By using an ex vivo surrogate
model of PEP, derived by isolating primary mouse and
human pancreatic acinar cells, we recently showed that
common radiocontrast agents used during ERCP induce
acinar cell inﬂammatory signaling and injury through the
activation of the calcium-activated phosphatase calcineurin
(Cn).5 In an in vivo model of PEP in mice, we found that
global Cn knockout mice (deﬁcient in CnAb) or systemic
inhibition of Cn with frequent dosing of the Cn inhibitors
FK506 or cyclosporine A (CsA) prevented PEP. Because Cn
is expressed ubiquitously, a crucial unanswered question is
whether acinar cell Cn blockade by itself is sufﬁcient to
prevent PEP in vivo.Materials and Methods
Reagents and Animals
All reagents were purchased from Sigma-Aldrich
(St. Louis, MO), unless speciﬁed otherwise. Mice carrying
loxP-ﬂanked (ﬂoxed) alleles of CnB1 (CnB1f/f; backcrossed to
a C57BL/6 strain) were a kind gift from Dr Gerald Crabtree.6
The Cre recombinase estrogen receptor T2 (Ela-CreERT2)
mutant line was a kind gift from Dr Craig Logsdon, and it
contains a transgenic insertion of a full-length acinar
cell-speciﬁc mouse pancreatic elastase I (Ela) promoter
that drives a tamoxifen-inducible CreERT2.7 This line
also was backcrossed to a C57BL/6 strain. Lox-Stop-Lox
(LSL)-tdTomato Red reporter (Tm) mice were obtained
from the Jackson Lab (Farmington, CT).8 Both male and fe-
male genetically engineered mice were used for the in vivo
studies. Eight- to 10-week-old wild-type male and female
Swiss Webster mice weighing 25 g were used to assess the
efﬁcacy of intraductal administration of FK506 and CsA. All
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and maintained on standard laboratory chow with free ac-
cess to food and water. All animal experiments were per-
formed using a protocol approved by the University of
Pittsburgh Institutional Animal Care and Use Committee.Generation of Conditional Pancreatic Acinar
Cell-Speciﬁc CnB1 Knockouts
CnB1f/f mice were crossed with Ela-CreERT2 mice to
generate homozygous Ela-CreERT2/CnB1f/f strains. To
delete CnB1 in pancreatic acinar cells (CnB1D/D), CreERT2/
CnB1f/f mice received a cumulative dose of 5–6 mg tamox-
ifen given intraperitoneally either daily or every other day
for a total duration of 5–6 days. PEP was induced 1 week
after the last tamoxifen injection. CnB1f/f lines lacking the
Ela-CreERT2 insertion served as controls, and they also
received tamoxifen.CnB1 D/D Genotyping
Genomic DNA was prepared from freshly isolated mouse
pancreas and liver tissue, as described.9 Brieﬂy, the tissue
was minced on ice and homogenized in sodium chloride
Tris-EDTA buffer containing proteinase K. The homoge-
nates were incubated at 55ºC for 3 hours with intermittent
vortexing. After inactivation of proteinase K, the homoge-
nates were centrifuged at 4ºC, and the supernatants con-
taining genomic DNA were precipitated with isopropanol.
The precipitated genomic DNA was pelleted at 4ºC, washed
with 70% ethanol, air-dried, and dissolved in 200 mL of
1  Tris-EDTA buffer for polymerase chain reaction. A
schematic of the location and size of the expected ampli-
cons are provided in Figure 1. Primer sequences are shown
in Table 1.
The polymerase chain reaction products were sepa-
rated on a 2% agarose gel and imaged. They were cut out,
puriﬁed, and sequenced. All sequences were aligned to
the National Center for Biotechnology Information data-
base and manually veriﬁed to conﬁrm CnB1 deletion and
that each component (eg, Ela, Cre, and ERT2) was in
frame.Nuclear Factor of Activated T Cells–Luciferase
Activity Assay
Isolated pancreatic acinar cells were infected with
nuclear factor of activated T cells–luciferase adenovirus as
previously described.10 Brieﬂy, cells were incubated with
adenovirus (titer 2  109 infectious units) for 30 minutes,
and then were exposed to radiocontrast for approximately 6
hours. After stimulation, cells were collected, washed with
phosphate-buffered saline once, lysed with 1 lysis buffer
(E397A; Promega, Madison, WI), and centrifuged at
12,000  g for 5 minutes at 4ºC. Luminescence was
measured from the supernatant using the Luciferase Assay
System (E1483; Promega) in a Synergy H1 plate reader
(BioTek, Winooski, VT), and total protein, determined by the
BCA kit (Thermo Scientiﬁc, Rockford, IL), was used to
normalize the data.Adeno-Associated Virus 6 Constructs
Adeno-associated virus (AAV)6 plasmids were generated
by cloning a pEla-iCre or pCMV-ZsGreen control vector into
a pAAV-multiple cloning site plasmid (VPK-410; Cell Bio-
labs, San Diego, CA), as previously described.11,12 Once
cloned, the AAV6 plasmid was transfected into HEK293 cells
along with 2 helper plasmids: (1) pAAV-RepCap (0912-06;
Applied Viromics, Fremont, CA), which is a packaging
plasmid that carries the serotype 6 rep and cap genes; and
(2) pHelper (0913; Applied Viromics), which is a plasmid
that carries the helper genes. Cells were collected 72 hours
after transfection and suspended in lysis buffer containing
50 mmol/L Tris, 150 mmol/L NaCl, and 2 mmol/L MgCl2.
Puriﬁcation of AAV6 for In Vivo Administration
AAV6 was puriﬁed as previously described.12,13 Brieﬂy,
transfected HEK293 cells were freeze-thawed 3 times to
release the AAV6 virus. Cell lysates were treated with
benzonase (0.05 U) at 37ºC for 30 minutes, followed by 1%
sodium deoxycholate at 37ºC for 30 minutes. Lysates were
spun at 2500  g for 10 minutes, and the supernatant was
collected. AAV6 was precipitated using a 1:4 mixture of 40%
polyethylene glycol (PEG-800) and 2.5 mol/L sodium
chloride for 2 hours at 0ºC. The solutionwas spun at 2500 g
for 30 minutes to collect the PEG pellet. The pellet was
resuspended in HEPES buffer (50 mmol/L), treated with an
equal volume of 100% chloroform, spun at 2500  g for 10
minutes, and air-dried for 30 minutes. Two-phase partition-
ing was performed using 50% ammonium sulfate and 40%
PEG-800 and spun at 2500  g for 15 minutes. The ammo-
nium sulfate phase was collected and dialyzed using a
10-kilodalton molecular weight cut-off Slide-A-Lyser Dialysis
Cassette (66810; Thermo Scientiﬁc) for 4 hours. Dialysis was
repeated a second time for 16 hours. The AAVs were
concentrated using a 50-kilodalton centrifugal ﬁlter unit
(UFC905024; Millipore, Billerica, MA) and stored at -80ºC.
The QuickTiter AAV Quantitation Kit (VPK-145; Cell Biolabs)
was used to measure viral concentrations.
Pancreatic Ductal Infusion of AAV6 Into CnB1f/f
Mice and Immunoﬂuorescence
The surgical procedure for retrograde pancreatic ductal
infusion of the AAV6 was as previously described.5 Brieﬂy,
100 mL of puriﬁed AAV6 (titer 2  1012 plaque-forming
units) was infused into the biliopancreatic duct at a rate
of 10 mL/min for 10 minutes using a P33 peristaltic syringe
pump (Harvard Apparatus, Holliston, MA). Surgical anes-
thesia was achieved by inhaling isoﬂurane and oxygen. A
single injection of the analgesic buprenorphine (0.075 mg/
kg) was given immediately after the surgery. Mice recovered
on a heating pad for 30 minutes and were housed for 4–6
weeks with free access to food and water before induction
of PEP. To verify the efﬁcacy of the AAV6 infusion, LSL-Tm
mice were used. One hundred microliters of puriﬁed
AAV6Ela-iCre (titer 2  1012 plaque-forming units) was
infused into the pancreatic duct as described earlier. Five
weeks after the surgery, pancreas tissue, along with the
abdominal organs en bloc, was imaged using a ﬂuorescence
Figure 1.Generation of acinar-speciﬁc Cn deletion using the Ela-CreERT2/CnB1f/f line. (A) Acinar cell Cn conditional knockout
line (CnB1D/D) induced by crossing Ela-CreERT2 mice with CnB1f/f mice, followed by tamoxifen administration. (B) Schema of
the CnB1 knockin allele containing loxP sites and schema of the Ela-CreERT2 transgene. Arrows denote forward and reverse
primers designed to generate polymerase chain reaction products for the 5’ and 3’ loxP sites, Cre, and ERT2. Agarose gels
showing the polymerase chain reaction products of expected size (C) in the non–tamoxifen-injected mice for the presence of
the ﬂoxed alleles and the Ela-CreERT2 transgene or (D) conﬁrming the ﬂoxed out state in the induced mouse. In the presence
of acinar-speciﬁc Cre expression, the resulting amplicon is expected to be 168 bp in length, as shown in the gel from the
pancreas, but not the liver of the CnB1D/D line. (E) Nuclear factor of activated T cells (NFAT) luciferase activity is diminished
markedly in acinar cells from CnB1D/D but not from CnB1f/f controls, in response to radiocontrast (RC). *,#P < .05 relative to
negative and positive controls, respectively. RLU, relative luminescence unit.
- 2016 Acinar Cell Calcineurin in PEP 3dissecting microscope, then sectioned and immunostained.
Polyclonal rabbit anti–a-amylase (Sigma) antibody was used
for labeling acini, and polyclonal guinea pig anti-insulin
(Dako, Carpinteria, CA) antibody was used for islets.
Secondary antibodies were purchased from Jackson Immu-
noResearch Labs (West Grove, PA). Ducts were labeled withbiotinylated Dolichos biﬂorus agglutinin lectin (Vector Labs,
Burlingame, CA). Nuclear staining was performed with
40,6-diamidino-2-phenylindole (Sigma). Images were
acquired using a LSM710 confocal laser scanning micro-
scope (Carl Zeiss, Jena, Germany). The percentage of acinar
cells showing red ﬂuorescence was quantiﬁed using the
Table 1.List of Primers Used in the Study
Target amplicon Forward primer Reverse primer Expected size, bp
5’loxp site TCTAGGTAATTAGGGCAGGTGC GCTTCTTGAATCTCTTTCCTAG 575
3’loxp site GACAGCTATACAGAGAAACCCTG AGCCTCCACATACACAGATAC 286
Cre GCCTGCATTACCGGTCGA TATCCTGGCAGCGATCGC 440
ERT2 GCGATCCACGAAATGAAATG GCAGGTTCATCATGCGGAAC 501
CnB1 (ﬂoxed out) CAATGCAGTCCGCTGTAGTTC AGCCTCCACATACACAGATAC 168
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Clara, CA), for a total of 18 ﬁelds at 200 magniﬁcation
from 2 independent mouse infusions. Acinar cells were
identiﬁed by co-staining for amylase and 40,6-diamidino-
2-phenylindole.
Induction of PEP
PEP was induced as previously described.5 Brieﬂy,
100 mL iohexol (Omnipaque 300; GE Healthcare, Princeton,
NJ) was infused retrograde into the biliopancreatic duct at a
rate of 20 mL/min for 5 minutes. Mice from the low-volume
normal saline (LVNS) intraductal infusion group received
retrograde infusion of 50 mL normal saline into pancreatic
duct at a lower rate of 10 mL/min for 5 minutes. Mice were
euthanized 24 hours after PEP induction by CO2 inhalation
and cervical dislocation. Mice from the sham group received
a laparotomy only. The experiments with the intraductal
administration of Cn inhibitors initially were performed in
females and then were replicated in both sexes. The
2 complementary conditional knockout experiments each
were performed in a single batch, based on the availability
of littermates as well as the relatively large volume of
AAV required for each mouse infusion. The experiments
with the intraductal administration of Cn inhibitors were
performed in 3 separate batches of mice.
Serum Amylase and Interleukin 6 Measurements
Blood was collected by retro-orbital bleed 6 hours after
PEP induction. Serum was prepared by centrifuging
at 1500  g for 10 minutes at 4ºC. Serum amylase was
measured using a Phadebas Kit (Amersham Pharmacia,
Rochester, NY), and interleukin (IL)6 was measured using a
standard enzyme-linked immunosorbent assay (Biolegend,
San Diego, CA).
Pancreatic Histopathology and Image Analysis
The pancreas, duodenum, and spleen were placed en
bloc in a cassette to maintain anatomic orientation. The
tissues were ﬁxed in 4% paraformaldehyde at room
temperature for 24 hours. Parafﬁn-embedded sections
were stained with H&E. Ten systematically selected ﬁelds
at 200 magniﬁcation were graded in a blinded fashion
from the head of the pancreas, which was identiﬁed by its
juxtaposition to the duodenum. The grading score gave
equal weight (from 0 to 3) for edema, inﬂammatory
inﬁltration, and necrosis, as described.14,15 Edema indices
were delineated further objectively by performingintensity thresholding using ImageJ software (National
Institutes of Health, Bethesda, MD). At least 5 images from
each slide were selected for the analysis. Each image was
set to the same color threshold. Labeled areas within the
parenchyma were marked as edema, and their surface area
was calculated as a percentage of the total parenchymal
area.
Immunohistochemistry
Immunohistochemistry for myeloperoxidase (MPO) was
performed from parafﬁn-embedded tissue sections using a
Leica Bond-Max Fully Automated immunohistochemistry
and in-situ hybridization (ISH) Staining System (Leica,
Buffalo Grove, IL) in a semiautomated manner. All of the
products for the immunohistochemistry for MPO were
purchased from Leica, including the primary antibody. The
slides were loaded on the Bond system, and the program
was set as follows: deparafﬁnized using Bond Dewax Solu-
tion (#AR9222), dehydrated with alcohol, incubated with
MPO (#PA0491; ready-to-use) primary antibody for 15
minutes and with a Bond polymer reﬁne detection kit
(#DS9800). The slides were washed automatically using
either Bond Wash Solution (#AR9590) or distilled water
between each steps. After systematic optimization of the
antibody using positive and negative control tissues, the
ideal conditions for MPO were with no pretreatment
needed, a 15-minute antibody incubation time, followed by
8 minutes post-primary and 8 minutes diaminobenzidine
tetrahydrochloride hydrate incubation. Five systematically
selected ﬁelds at 50 magniﬁcation were graded in a blin-
ded fashion from the head of the pancreas. A score from 0 to
3 was used to grade the extent of brown color in each ﬁeld.
Statistical Analysis
Data were expressed as means ± SEM, unless otherwise
speciﬁed. Statistical analysis was performed using GraphPad
Prism 6 (La Jolla, CA). Comparisons were performed using
an unpaired t test. A P value of .05 or less was considered
signiﬁcant.
Results
To delete Cn selectively in pancreatic acinar cells, we
crossed a mouse line containing ﬂoxed alleles for the critical
regulatory subunit B1 (CnB1) with a tamoxifen-inducible
Cre line driven by a full-length acinar-speciﬁc mouse Ela
promoter7 (Figure 1). A mild model of PEP was ﬁrst
induced by infusing LVNS into the biliopancreatic duct. In
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Figure 3. Acinar cell-speciﬁc deletion of Cn protects against bile acid infusion pancreatitis in mice. (A) Left: representative H&E
sections, right: overall histologic severity. Histologic subscoring for (B) edema, (C) inﬂammation, and (D) necrosis. (E) Serum
IL6 level at 24 hours (n ¼ 3–4 animals per condition). #P < .05 relative to each positive control.
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reduction in histologic damage among the acinar cell-
speciﬁc CnB1-deﬁcient mice (CnB1D/D) (Figure 2).
Furthermore, we developed a more severe model of injury
that mimics PEP by infusing radiocontrast at double the
volume and rate of infusion within the same time frame
as the mild model. In this model, we observed that the
CnB1D/D mice also had a marked reduction in histologic
damage by 75%, down to the level of the sham-operated
negative control arm. Each parameter of the overallFigure 2. (See previous page). Acinar cell-speciﬁc deletion o
protects against PEP. (A) Timeline for tamoxifen injections, follow
pancreatic head from sham-operated LVNS intraductal infusion
severity scoring. (C) Subscoring for edema, inﬂammation, and
image thresholding. (E) Serum IL6 and (F) MPO immunohistoche
per condition). *,#P < .05 relative to control sham and each poshistologic score was diminished, including edema, inﬂam-
matory inﬁltrate (additionally examined by MPO staining),
and necrosis. Serum IL6 increase also was reduced mark-
edly. These ﬁndings indicate that acinar cell Cn mediates
PEP in vivo. In addition to the mild and moderate models of
PEP, we observed that the acinar cell-speciﬁc Cn deletion
also protected against a disparate model of acute pancrea-
titis induced by infusion of the bile acid taurocholate
(Figure 3). The ﬁndings lend further support to the broad
importance of acinar cell Cn in mediating pancreatic injury.f Cn in the tamoxifen-induced Ela-CreERT2/CnB1f/f mouse
ed by PEP induction. (B) Representative H&E sections of the
, and PEP modeled conditions, along with overall histologic
necrosis from the pancreatic head. (D) Edema, assessed by
mistry staining (left), and quantiﬁcation (right) (n ¼ 3–4 animals
itive control, respectively.
Figure 4. Intraductal infusion
of a novel AAV6-Ela-iCre
construct targets the pancre-
atic acinar cell. (A) Schema of
the AAV6-Ela-iCre plasmid,
(B) LSL-Tmmicewere infused
with AAV6-Ela-iCre to
examine the depth of Cre
expression in acinar cells and
acinar cell speciﬁcity. Red
ﬂuorescencewasobserved in
the pancreas and excluded
fromneighboringorganssuch
as the small intestine (SI), liver
(L), and spleen (Sp). In the tis-
sue sections, the dashed
white line separates pancreas
(left) from duodenum (right).
(C) Immunoﬂuorescence from
pancreatic sections for acinar
cells (amylase; blue), duct
cells (Dolichos biﬂorus agglu-
tinin lectin; green), and islets
(insulin; white) in LSL-Tm
mice. (D) Quantiﬁcation of
the percentage of acinar cells
showing red ﬂuorescence. (E)
Schema for intraductal
infusion of AAV6-Ela-iCre into
CnB1f/f mice to delete Cn. (F)
Expected polymerase chain
reaction product of 168 bp
seen in the pancreas from
AAV6-Ela-iCre–infused mice,
but not with AAV6 control
infusion. (G) Western blot for
CnB1 on top and densitom-
etry at bottom with error bar
representing SD. GAPDH,
glyceraldehyde-3-phosphate
dehydrogenase. ITR, inverted
terminal repeat.
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Cn knockouts by generating an AAV6 vector, which houses
an enhanced version of Cre (iCre)16 that is driven by a
shorter, independently constructed rat Ela promoter17
(Figure 4). Among serotypes, AAV6, along with AAV8, offer
the highest infection efﬁciency into acinar cells.12,18 As proof
of principle for targeting acinar cells, the AAV6-Ela-iCre
induced acinar cell ﬂuorescence in LSL-Tm mice. Immuno-
staining conﬁrmed that the activation of iCre is restricted
largely to acinar cells, but not ducts and islets. The per-
centage of acinar cells showing red ﬂuorescence was 37% ±
3.88% and Western blot from the head of the pancreas
showed that CnB1 expression was reduced by 33%
(Figure 4). Despite the modest reduction in Cn, these mice
were protected against PEP (Figure 5).Systemic inhibition of Cn with administration of multiple
doses of Cn inhibitors before and after PEP induction was
shown previously to protect against PEP.5 However, the
current ﬁndings, with the 2 genetic Cn deletion models, that
acinar cell Cn in vivo is necessary for PEP prompted us to
question whether selectively targeting acinar cell Cn activity
by administering a single, acute dose of Cn inhibitor, along
with the radiocontrast infusion, could mitigate PEP. This
unique compartmentalized method of delivery of a small
amount of drug would additionally reduce the toxicity
proﬁle of the inhibitors. FK506 (1 mmol/L) and CsA
(10 mmol/L) each were dissolved easily in the ready-to-use
iohexol formulation, and the concentrations of each were
chosen based on our previous ex vivo data.5 In contrast to
the ﬁnding with the CnB1 conditional knockouts (ie, the
Figure 5. Acinar cell-speciﬁc deletion of Cn by AAV6-Ela-iCre in CnB1f/f mouse protects against PEP. (A) Timeline for AAV6
infusion, followed by PEP induction. (B) Representative H&E sections from sham control and PEP conditions, along with
overall histologic severity scoring. (C) Subscoring for edema, inﬂammation, and necrosis from the pancreatic head. (D) Edema,
assessed by image thresholding. (E) MPO immunohistochemistry staining (left) and quantiﬁcation (right) (n ¼ 3–4 animals per
condition). *,#P < .05 relative to control sham and each positive control, respectively.
8 Orabi et al Cellular and Molecular Gastroenterology and Hepatology Vol. -, No. -
Figure 6. Intraductal (ID) administration of Cn inhibitors along with the radiocontrast infusion prevents PEP. (A) Representa-
tive H&E sections from sham-operated, LVNS, and PEP modeled conditions. The Cn inhibitors FK506 (1 mmol/L) or CsA
(10 mmol/L) were delivered intraductally with the radiocontrast solution. (B) Overall histologic severity scoring. (C) Subscoring
for edema, inﬂammation, and necrosis. (D) Serum IL6 level also at 24 hours and (E) serum amylase level at 6 hours (n ¼ 3–10
animals per condition). *,#P < .05 relative to the control sham and each positive control, respectively.
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10 Orabi et al Cellular and Molecular Gastroenterology and Hepatology Vol. -, No. -CnB1D/D line), intraductal FK506 or CsA therapy did not
affect the mild histologic damage seen with LVNS (Figure 6).
This differential response likely represents incomplete Cn
blockade with the current dosing schema. However, this
pharmacologic intervention reduced the severity in the
moderate model of PEP by 61% and 37% down to sham
levels, respectively. Both serum IL6 and amylase levels also
were reduced signiﬁcantly.
Discussion
In summary, using 2 complementary genetic approaches
to delete acinar cell Cn in vivo and in 2 severity models of
PEP in mice, as well as a bile infusion model of pancreatitis,
we show that PEP and pancreatitis can be largely prevented
by acinar cell Cn deletion. Notably, even a partial deletion of
acinar Cn (by approximately one third with the intraductal
AAV strategy) led to marked protection against PEP. The
translational corollary to these signiﬁcant ﬁndings is that
intraductal delivery of Cn inhibitors, to target acinar cell Cn
in vivo, also was shown to reduce PEP. These novel ﬁndings
reconcile the paradox that chronic and systemic adminis-
tration of Cn inhibitors could predispose to pancreatitis and
pancreatic ﬁbrosis,19,20 whereas acute and targeted delivery
to the pancreas protects against pancreatitis. This work
provides the impetus for launching clinical trials to test the
efﬁcacy of a novel ERCP infusion formulation containing Cn
inhibitors to prevent PEP.References
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